AstraZeneca bags another cancer drug deal, this time with Inovio

ReutersAstraZeneca bags another cancer drug deal, this time with InovioReutersLONDON AstraZeneca has clinched its third deal in less than a week to bolster its strategically important cancer drug pipeline by signing up rights to an experimental immune system-boosting medicine from Inovio Pharmaceuticals. Inovio will get $27.5 ...Inovio Pharmaceuticals Enters Into Strategic Cancer Vaccine Collaboration and ...CNNMoneyAstraZeneca to Pay Inovio Up to $700 Million for Cancer MedicineBloombergShares of Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Drops by -10.97%News Watch InternationalLondon South East -sleekmoneyall 9 news articles »